Healthcare Global Enterprises Limited's Board of Directors has approved the introduction and adoption of a new employee stock option scheme during their meeting held on February 05, 2026. The HCG Employee Stock Option Scheme 2026 (HCG ESOS 2026) was approved based on recommendations from the company's Nomination and Remuneration Committee.

ESOP Scheme Details

The newly approved employee stock option scheme encompasses significant parameters for employee benefits:

Vesting and Exercise Framework

The scheme will be administered by the Nomination and Remuneration Committee, with specific guidelines for vesting periods:

• Minimum vesting period: 1 year from grant date
• Maximum vesting period: 7 years from grant date
• Exercise timeline: As per ESOP scheme terms
• Committee oversight: NRC will determine specific vesting schedules

Pricing Structure

The exercise price structure follows a tiered approach based on grant timing. For options granted prior to June 30, 2026, the exercise price is fixed at INR 495. For options granted after June 30, 2026, the Nomination and Remuneration Committee will determine the price, ensuring it remains not below INR 495.

Regulatory Compliance and Approval Process

The HCG ESOS 2026 aligns with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The board meeting, which commenced at 12 noon and concluded at 7.35 p.m. IST, addressed the regulatory requirements under Regulation 30 of SEBI Listing Regulations.

Key compliance aspects:

• Subject to shareholders' approval
• Detailed explanatory statement for shareholders' meeting
• Full regulatory disclosure requirements met
• SEBI circular compliance maintained

Current Status

As this represents a new employee stock option plan, no options have been vested, exercised, or lapsed to date. The scheme implementation awaits shareholder approval, after which the company can proceed with grant allocations to eligible employees. The board's decision reflects the company's commitment to employee retention and incentivization through equity participation.

Healthcare Global Enterprises Limited has announced a key addition to its senior management team with the appointment of Mr. Pankaj Gautam as Chief Information Officer. The appointment was approved by the Board of Directors at their meeting held on February 05, 2026, following recommendations from the Nomination and Remuneration Committee.

Appointment Details

The regulatory filing submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that Mr. Gautam will join the company on or before February 15, 2026. He will form part of the Senior Management Personnel of HealthCare Global Enterprises Limited.

Professional Background

Mr. Pankaj Gautam brings extensive experience to his new role, with over 20 years of leadership experience in enterprise-wide transformation across major healthcare organizations. His expertise spans multiple critical areas of healthcare technology and operations.

Key Areas of Expertise

• Digital health and technology strategy
• Operational leadership in healthcare settings
• Technology-enabled care model scaling
• Integrated Health Delivery Networks
• Enterprise HIS/EMR-EHR platforms

Previous Experience

Gautam has held leadership positions at several prominent healthcare organizations, where he has driven significant technological initiatives. His career includes tenures at Rainbow Children's Hospitals, Glenhealth Works, and Apollo, where he led high-impact transformation projects.

Regulatory Compliance

The appointment follows all regulatory requirements under SEBI LODR Regulations. The company has filed the necessary disclosures with both the National Stock Exchange of India Limited and BSE Limited, ensuring full compliance with listing obligations. The detailed information has been provided in accordance with Regulation 30(6) and the SEBI Master Circular dated January 30, 2026.